USRM Posts 25% Nine Month Revenue Increase From 3Q 2017
Profit Margins Continue to Increase As Costs And Operating Expenses Decrease SUNRISE, FL – November 06, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of…
Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers
Paper Published by USRM Chief Science Officer in Journal of Medical Cases SUNRISE, FL – October 9, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development…
USRM Chief Science Officer Featured on YourVoice™ America
SUNRISE, FL – October 1, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
Dr. Kristin Comella Joins Top Docs in Fix for Female Hormones Seminar
SUNRISE, FL – September 26, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
CEO Blog: September 2018: An Accomplished Summer
Dear Shareholders and Friends, Thank you for your continued interest and support in U.S. Stem Cell, Inc.’s recent developments and achievements. As we continue to grow, our main focus continues…
USRM Hires Senior VP of US & International Sales
USRM Hires Senior VP of US & International Sales Former Abbott Pharmaceuticals, Stem Cell Centers Exec Joins Team _________________________________________ SUNRISE, FL – September 11, 2018 – U.S. Stem Cell, Inc….
USRM Posts Profitable Results for Second Quarter 2018
SUNRISE, FL – August 8, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
Stem Cells Shows Promise For Repairing Torn Meniscus
SUNRISE, FL – July 10, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
‘Renewing Our Heroes’ to Provide USRM Stem Cell Protocol to First Responders
SUNRISE, FL – June 5, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference
SUNRISE, FL – June 1, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with ‘Something Significant’ Happy Living Podcast
SUNRISE, FL – May 17, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference
SUNRISE, FL – May 15, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…